<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01643707</url>
  </required_header>
  <id_info>
    <org_study_id>IMPROVE Brady</org_study_id>
    <nct_id>NCT01643707</nct_id>
  </id_info>
  <brief_title>Registry to Improve the Adoption of Consensus Treatment Guidelines (IMPROVE Brady)</brief_title>
  <acronym>IMPROVE Brady</acronym>
  <official_title>Registry to Improve the Adoption of Consensus Treatment Guidelines (IMPROVE Brady)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiac Rhythm and Heart Failure</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiac Rhythm and Heart Failure</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Registry to Improve the Adoption of Consensus Treatment Guidelines (IMPROVE Brady)

      The study is expected to provide evidence to support claim(s) that:

        -  Education and process improvement initiatives can improve the diagnosis of and
           appropriate therapy application for sinus node dysfunction (SND)

        -  The quality improvement methods studied have general applicability and can be used by
           all centers

        -  Appropriate treatment minimizes caregiver burden

        -  Appropriate treatment improves quality of life (QOL) and functional status compared to
           pre-implant
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2012</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The absolute change in the proportion of subjects diagnosed with SND before and after intervention</measure>
    <time_frame>Assessed at 6 and 12 months of follow-up from enrollment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The absolute change in the proportion of subjects receiving indicated therapy before and after intervention</measure>
    <time_frame>Assessed at 3 and 6 months of follow-up from SND diagnosis</time_frame>
    <description>Outcome measure applies to subjects that receive a SND diagnosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The proportion of Phase I subjects diagnosed with SND and the number of diagnoses that result in indicated therapy</measure>
    <time_frame>SND diagnosis assessed at 6 and 12 months of follow-up from enrollment and receipt of therapy assessed at 3 and 6 months of follow-up from SND diagnosis</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in time to diagnosis of SND before and after intervention</measure>
    <time_frame>From date of enrollment until date of SND diagnosis, assessed up to 60 months</time_frame>
    <description>Time to diagnosis days (date of diagnosis - date of enrollment)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in time to receiving an indicated IPG device for subjects diagnosed with SND before and after intervention</measure>
    <time_frame>From date of SND diagnosis until date of therapy, assessed up to 60 months</time_frame>
    <description>Time to diagnosis in days (date of implant - date of diagnosis)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in caregiver burden between implant visit and 6 months post-implant</measure>
    <time_frame>between implant visit and 6 months post-implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life (QOL) between implant visit and 6 months post-implant</measure>
    <time_frame>between implant visit and 6 months post-implant</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">14850</enrollment>
  <condition>Sinus Node Dysfunction</condition>
  <arm_group>
    <arm_group_label>Phase I</arm_group_label>
    <description>Control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase II</arm_group_label>
    <description>Treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Evidence based guidelines and tools</intervention_name>
    <description>Education, guidelines, tools</description>
    <arm_group_label>Phase II</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with possible sinus node dysfunction
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is at least 18 years of age

          -  Patient's heart rate meets at least one of the following:

               -  Patient has a sinus rate â‰¤ 50 OR a junctional escape rhythm no faster than 50

               -  Patient has a history of exercise intolerance

          -  Patient complains of general fatigue, shortness of breath, shortness of breath with
             exertion, syncope, light headed dizziness, palpitations, lethargy, dyspnea OR malaise
             within the last 30 days that are not related to other discovered causes (such as
             untreated hypothyroidism or anemia).

          -  Patient (or patient's legally authorized representative) is willing and able to sign
             and date written Patient Consent Form/Patient Data Release Consent

        Exclusion Criteria:

          -  Patient has type II 2nd degree AV block, High degree AV block (2:1, 3:1, 4:1 etc.) or
             3rd degree AV block

          -  Patient has recent history of blood loss

          -  Patient has a medical history leading to suspicion of neurological disorder

          -  Patient has a history of Chronic Atrial Fibrillation

          -  Patient is enrolled or planning to participate in a concurrent drug and/or device
             study at any time during the course of this clinical study without documented
             pre-approval from the Medtronic study manager

          -  Patient is not expected to survive for 12 months

          -  Patient is anticipated to be unwilling or unable to comply with the clinical
             investigation plan
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>IMPROVE Brady Study Team</last_name>
    <email>medtroniccrmtrials@medtronic.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital General de Agudos</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos Labadet</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Heart Foundation Hospital and Research Institute</name>
      <address>
        <city>Dhaka</city>
        <country>Bangladesh</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fazila-Tu- Nesa Malik</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>United Hospital Limited</name>
      <address>
        <city>Dhaka</city>
        <country>Bangladesh</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaisar Nasrullah Khan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CARE Hospitals</name>
      <address>
        <city>Hyderabad</city>
        <state>Andhra Pradesh</state>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Calambur Narasimhan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Max Balaji Hospital</name>
      <address>
        <city>New Delhi</city>
        <state>DL</state>
        <country>India</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Care Insitute of Medical Sciences</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ajay Naik</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>RajaRajeswari Medical College &amp; Hospital</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yogesh Kothari</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Madras Medical Mission Institute of Cardiovascular Diseases</name>
      <address>
        <city>Chennai</city>
        <state>Tamil Nadu</state>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulhas Pandurangi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>King George's Medical University</name>
      <address>
        <city>Lucknow</city>
        <state>Uttar Pradesh</state>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rishi Sethi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Mission Hospital</name>
      <address>
        <city>Bidhannagar Durgapur</city>
        <state>West Bengal</state>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashok Parida</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Max Devki Devi Heart and Vascular Institute</name>
      <address>
        <city>New Dehli</city>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanita Arora</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Medico Nacional de Occidente IMSS</name>
      <address>
        <city>Mexico City</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Jose Garcia Pinto</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Central Militar</name>
      <address>
        <city>Mexico City</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alfredo Echegaray Trelles</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UMAE Hospital de Cardiologia Centro Medico nacional Siglo XXI IMSS</name>
      <address>
        <city>Mexico City</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moises Calderon</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Nacional Carlos Alberto SeguÃ­n Escobedo</name>
      <address>
        <city>Arequipa</city>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pedro Torres Equiluz</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional Cardiovascular</name>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jorge Salinas Arce</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Amur State Medical Academy</name>
      <address>
        <city>Blagoveschensk</city>
        <zip>675006</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Chelyabinsk Federal Center of Cardiovascular Surgery</name>
      <address>
        <city>Chelyabinsk</city>
        <zip>454003</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Federal Center of Cardio-Vascular Surgery</name>
      <address>
        <city>Krasnoyarsk</city>
        <zip>660020</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Center of Modern Cardiology</name>
      <address>
        <city>Krasnoyarsk</city>
        <zip>660093</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Casa de Galicia</name>
      <address>
        <city>Montevideo</city>
        <country>Uruguay</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Walter Reyes Caorsi</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Bangladesh</country>
    <country>India</country>
    <country>Mexico</country>
    <country>Peru</country>
    <country>Russian Federation</country>
    <country>Uruguay</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2012</study_first_submitted>
  <study_first_submitted_qc>July 16, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 18, 2012</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sick Sinus Syndrome</keyword>
  <keyword>Bradycardia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sick Sinus Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

